港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

686.108

-31.133-4.34%

漲家數：4

跌家數：6

平家數：3

市盈率：- -

高：696.344

開：678.885

低：675.692

收：717.241

資料載入中...

四環醫藥：惠升生物研發的達格列淨片獲國家藥監局上市批准

四環醫藥(00460)：惠升生物研發的達格列淨片獲國家藥監局上市批准

現代牙科回購10萬股金額43萬港元

現代牙科(03600)4月23日耗資約42.78萬港元回購10萬股

復星醫藥(02196)：李東久辭去高級副總裁職務

復鋭醫療科技高管團隊一行到訪星榮醫院研討共築醫美產學研醫創新高地

每日賣空追蹤 | 康哲藥業 04月23日賣空量成交279.8萬股，賣空比例為11.89%

康哲藥業分拆“德鎂醫藥”，來自海南海口，擬以介紹方式赴香港上市，遞交上市申請

港股異動 | 時代天使(06699)漲超4% 公司股東李華敏收購上海愷皓40%股權

康哲藥業盤中漲超4% 建議分拆德鎂醫藥股份於聯交所主板獨立上市

港股異動 | 康哲藥業(00867)漲超4% 建議分拆德鎂醫藥股份於聯交所主板獨立上市

康哲藥業盤中異動早盤股價大漲5.04%報8.550港元

【灣區早參】香港最新失業率維持3.2%；澳門推出《2025年中小企業銀行貸款利息補貼計劃》

康哲藥業：分拆德鎂醫藥上市潛力有望迎來釋放

康哲藥業(00867)建議分拆德鎂醫藥股份於聯交所主板獨立上市

山河藥輔增收不增利！董事長連年漲薪，大股東復星醫藥頻繁減持套現

读创客户端

非執行董事張皎娥減持三生製藥(01530)2.6萬股每股作價12.94港元

智通财经网

復星醫藥收盤上漲2.09%，滾動市盈率23.53倍，總市值651.80億元

三生製藥04月22日主力淨流入764萬元散户資金拋售

四環醫藥04月22日主力淨流入924萬元散戶資金拋售

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":686.1075,"timestamp":1745827736034,"preClose":717.24054,"halted":0,"volume":158238758,"delay":0,"changeRate":-0.043407,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-31.133057,"latestTime":"04-28 16:00:00","open":678.8851,"high":696.34436,"low":675.6922,"amount":1315776884,"amplitude":0.028794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.007817,"increases":3,"decrements":7,"flats":3,"marketCap":118158594152,"floatMarketCap":82270515368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":696.34436,"amplitude":0.028794,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":686.1075,"volume":158238758,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.007817,"peRate":19.315719,"marketCap":118158594152,"floatMarketCap":82270515368,"timestamp":1745827736034,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529285696","title":"四環醫藥：惠升生物研發的達格列淨片獲國家藥監局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529285696","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529285696?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 08:13","pubTimestamp":1745453580,"startTime":"0","endTime":"0","summary":"　　四环医药发布公告，集团旗下非全资附属公司惠升生物制药股份有限公司研发的达格列净片已获中华人民共和国国家药品监督管理局颁发的药品注册批件，用于2型糖尿病成人患者，视同通过仿制药品质和疗效一致性评价。　　达格列净片为全球首款获批上市的SGLT-2抑制剂。该产品为国家医保产品，国家基本药物。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-24/doc-ineufnmc3678298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00460","BK1515","BK1600","BK1593","BK1191"],"gpt_icon":0},{"id":"2529500411","title":"四環醫藥(00460)：惠升生物研發的達格列淨片獲國家藥監局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500411","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500411?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 20:40","pubTimestamp":1745412034,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布公告，集团旗下非全资附属公司惠升生物制药股份有限公司研发的达格列净片已获中华人民共和国国家药品监督管理局颁发的药品注册批件，用于2型糖尿病成人患者，视同通过仿制药品质和疗效一致性评价。达格列净片为全球首款获批上市的SGLT-2抑制剂。该产品为国家医保产品，国家基本药物。达格列净片是惠升生物继脯氨酸加格列净片、恩格列净片后获得上市批准的第三个SGLT-2抑制剂类药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"四环医药(00460)：惠升生物研发的达格列净片获国家药监局上市批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","00460","BK1191","BK1600","BK1593"],"gpt_icon":0},{"id":"2529502149","title":"現代牙科回購10萬股 金額43萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529502149","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529502149?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 20:03","pubTimestamp":1745409821,"startTime":"0","endTime":"0","summary":"现代牙科（03600）发布公告，2025年4月23日，公司回购股份10万股，回购金额为43万港元。根据回购授权的决议，公司可回购的股份总数为9484万股，已回购股份775万股，占回购授权决议通过时已发行股份的0.817%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233386058613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK1100","BK1583","03600"],"gpt_icon":0},{"id":"2529340509","title":"現代牙科(03600)4月23日耗資約42.78萬港元回購10萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529340509","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529340509?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 19:26","pubTimestamp":1745407599,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)公布，2025年4月23日耗资约42.78万港元回购10万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","03600","BK1100","BK1583"],"gpt_icon":0},{"id":"2529505467","title":"復星醫藥(02196)：李東久辭去高級副總裁職務","url":"https://stock-news.laohu8.com/highlight/detail?id=2529505467","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529505467?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 19:02","pubTimestamp":1745406121,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，因到龄退休，李东久向董事会申请辞去高级副总裁职务。李东久自2025年4月23日起不再担任公司高级副总裁职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0183","BK0196","02196","BK0187","BK0175","BK1191","BK0012","BK0096","BK0028","BK0060","BK1515","BK1593","600196","BK0239"],"gpt_icon":0},{"id":"2529398046","title":"復鋭醫療科技高管團隊一行到訪星榮醫院 研討共築醫美產學研醫創新高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398046","media":"复星医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529398046?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 17:16","pubTimestamp":1745399784,"startTime":"0","endTime":"0","summary":"2025年4月22日，复锐医疗科技有限公司高管团队一行到访复星健康医美旗舰品牌重庆星荣整形外科医院。依托复星全球医疗产业生态资源，星荣整形已构建起集医疗技术、美学设计与科研转化于一体的高端医美服务体系。复锐医疗科技是中国领先的医疗健康产业集团复星医药的控股子公司，于2017年9月在中国香港上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423225317a6c5507f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423225317a6c5507f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","600196","BK1593","01696","BK1100","BK1585"],"gpt_icon":0},{"id":"2529578580","title":"每日賣空追蹤 | 康哲藥業 04月23日賣空量成交279.8萬股，賣空比例為11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529578580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529578580?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 17:09","pubTimestamp":1745399368,"startTime":"0","endTime":"0","summary":"康哲药业北京时间04月23日，涨4.79%，卖空量成交279.8万股，较上一交易日增加148.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015986.USD","SG9999015945.SGD","BK1593","00867","SG9999015978.USD","SG9999015952.SGD","LU2488822045.USD","SG9999004220.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2529545328","title":"康哲藥業分拆“德鎂醫藥”，來自海南海口，擬以介紹方式赴香港上市，遞交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2529545328","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529545328?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 13:04","pubTimestamp":1745384640,"startTime":"0","endTime":"0","summary":"　　2025年4月22日，康哲药业分拆德镁医药有限公司Dermavon Holdings Limited在港交所递交上市申请，拟以介绍方式在香港主板上市。　　德镁医药，成立于2020年，总部位于海南海口，作为一家中国领先、专业聚焦皮肤健康的创新型医药企业，围绕皮肤处方药及皮肤学级护肤品的研、产、销一体化运营，致力于提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-23/doc-ineucptw3299749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00867","BK1161","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","BK1191","SG9999015945.SGD","IE00BMCWC346.EUR","SG9999015978.USD","159938","BK1574","BK1515","SG9999004220.SGD","09939","IE00BYV24P56.USD","BK1593"],"gpt_icon":0},{"id":"2529153095","title":"港股異動 | 時代天使(06699)漲超4% 公司股東李華敏收購上海愷皓40%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2529153095","media":"智通财经","labels":["shareholding","merge","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529153095?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 10:41","pubTimestamp":1745376090,"startTime":"0","endTime":"0","summary":"消息面上，4月22日，时代天使发布公告，上海恺皓已成为公司的关联人士，原因是公司主要股东李华敏已收购上海恺皓总股权的40%。因此，上海恺皓与公司之间的加工承包协议项下的持续交易已成为公司的持续关联交易。加工承包协议于2024年10月28日签订，主要条款包括上海恺皓根据无锡时代天使的购买订单提供原材料加工服务，协议有效期至2025年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06699","BK1100","BK1583","BK1593"],"gpt_icon":0},{"id":"2529851655","title":"康哲藥業盤中漲超4% 建議分拆德鎂醫藥股份於聯交所主板獨立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529851655","media":"新浪网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529851655?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 10:32","pubTimestamp":1745375552,"startTime":"0","endTime":"0","summary":"康哲药业盘中涨超4%，截至发稿，股价上涨2.95%，现报8.38港元，成交额7606.41万港元。4月22日晚间，康哲药业发布公告，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆（倘进行）预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015986.USD","BK1593","BK1191","BK1515","BK1574","BK1161","SG9999015978.USD","00867"],"gpt_icon":0},{"id":"2529920385","title":"港股異動 | 康哲藥業(00867)漲超4% 建議分拆德鎂醫藥股份於聯交所主板獨立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529920385","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529920385?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:50","pubTimestamp":1745373044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康哲药业涨超4%，截至发稿，涨4.67%，报8.52港元，成交额3570.65万港元。消息面上，4月22日晚间，康哲药业发布公告，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","SG9999015978.USD","BK1161","00867","BK1574","SG9999015986.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015952.SGD","SG9999004220.SGD","IE00BYV24P56.USD","BK1191","159938","09939","BK1593","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2529592679","title":"康哲藥業盤中異動 早盤股價大漲5.04%報8.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529592679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529592679?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:37","pubTimestamp":1745372279,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘09时37分，康哲药业股票出现波动，股价急速上涨5.04%。截至发稿，该股报8.550港元/股，成交量219.3万股，换手率0.09%，振幅4.05%。资金方面，该股资金流入1027.73万港元，流出598.138万港元。最近的财报数据显示，该股实现营业收入80.66亿港元，净利润17.49亿港元，每股收益0.72港元，毛利58.55亿港元，市盈率11.92倍。康哲药业股票所在的药品行业中，整体涨幅为0.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015952.SGD","IE00BMCWC346.EUR","00867","BK1191","SG9999015945.SGD","SG9999004220.SGD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","BK1593","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2529932805","title":"【灣區早參】香港最新失業率維持3.2%；澳門推出《2025年中小企業銀行貸款利息補貼計劃》","url":"https://stock-news.laohu8.com/highlight/detail?id=2529932805","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529932805?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 08:20","pubTimestamp":1745367606,"startTime":"0","endTime":"0","summary":"就业不足率在该两段期间亦保持不变，维持于1.1%的水平。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1593","02068","LU0164865239.USD","LU1226288253.USD","LU1522347837.USD","00867","BK1161","BK1144","IE00BMCWC346.EUR","BK1224","BK1152","BK1574","LU1226288170.HKD","LU2543165471.USD","SG9999015986.USD","09992","LU0039217434.USD","LU2488822045.USD","LU1497733557.USD","SG9999015978.USD","LU0348766576.USD","LU1634259391.SGD","LU1226287875.USD","LU0823426480.USD","LU0531971595.HKD","LU0348767384.USD","SG9999002950.SGD","BK1536","BK1521","LU1497734951.SGD","02218","01057","LU0164880469.USD","LU1481107354.HKD","01672","00941","IE00BYV24P56.USD","LU0871576103.HKD","LU1226287792.SGD","LU1226287529.USD","LU0823426308.USD","LU1634259557.SGD","BK1505","SG9999004220.SGD","BK1237","BK1515","SG9999015952.SGD","80883","LU1951186391.HKD"],"gpt_icon":1},{"id":"2529996305","title":"康哲藥業：分拆德鎂醫藥上市 潛力有望迎來釋放","url":"https://stock-news.laohu8.com/highlight/detail?id=2529996305","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529996305?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 00:00","pubTimestamp":1745337600,"startTime":"0","endTime":"0","summary":"公司近况4 月22 日晚，公司公告建议分拆子公司德镁医药于港交所主板独立上市，分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。根据公告，建议分拆（若进行）采用实物方式向股东分派其持有所有德镁医药股份方式实施，股东享有的德镁医药股权不会被稀释。目前德镁医药90.8%股权由康哲药业持有，9.2%股权由两个员工激励平台持有。分拆完成上市后，康哲药业与德镁医药将各自拥有独立上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","LU2488822045.USD","SG9999015978.USD","SG9999015986.USD","SG9999015952.SGD","BK1191","00867","BK1574","SG9999004220.SGD","09939","IE00BMCWC346.EUR","BK1161","IE00BYV24P56.USD","BK1515","SG9999015945.SGD"],"gpt_icon":0},{"id":"2529585619","title":"康哲藥業(00867)建議分拆德鎂醫藥股份於聯交所主板獨立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529585619?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:36","pubTimestamp":1745329000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。据悉，德镁医药是一家在开曼群岛注册成立的获豁免有限公司，为公司的附属公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015986.USD","BK1593","159938","BK1191","BK1515","BK1574","BK1161","SG9999015978.USD","00867"],"gpt_icon":0},{"id":"2529637242","title":"山河藥輔增收不增利！董事長連年漲薪，大股東復星醫藥頻繁減持套現","url":"https://stock-news.laohu8.com/highlight/detail?id=2529637242","media":"读创客户端","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529637242?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 19:08","pubTimestamp":1745320115,"startTime":"0","endTime":"0","summary":"进入2025年，山河药辅同样面临增收不增利的困境。股东方面，截至一季度末，尹正龙持有山河药辅26.90%股权，为其控股股东；上海复星医药产业发展有限公司持有山河药辅10.16%股权，为其第二大股东。2月23日晚间，山河药辅公告称，股东复星医药因经营需要拟减持本公司股份不超过697.8万股，即不超过公司总股本的3%。以此计算，复星医药套现约2770.27万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042219152794de0564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042219152794de0564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2529303508","title":"非執行董事張皎娥減持三生製藥(01530)2.6萬股 每股作價12.94港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529303508","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529303508?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 18:56","pubTimestamp":1745319360,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月15日，非执行董事张皎娥减持三生制药(01530)2.6万股，每股作价12.94港元，总金额为33.644万港元。减持后最新持股数目约为1249.26万股，最新持股比例为0.52%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzzsn7529454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","BK1583","BK1161","01530"],"gpt_icon":0},{"id":"2529277653","title":"復星醫藥收盤上漲2.09%，滾動市盈率23.53倍，總市值651.80億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529277653","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529277653?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 17:56","pubTimestamp":1745315803,"startTime":"0","endTime":"0","summary":"4月22日，复星医药今日收盘24.4元，上涨2.09%，滚动市盈率PE达到23.53倍，创13天以来新低，总市值651.80亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均47.61倍，行业中值28.57倍，复星医药排名第76位。截至2024年年报，共有39家机构持仓复星医药，其中基金39家，合计持股数6857.75万股，持股市值17.03亿元。上海复星医药(集团)股份有限公司的主营业务是制药、医疗器械、医学诊断、医疗健康服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/22175649755974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK0060","600196","02196","BK0096","BK0196","BK0175","BK0028","BK1191","BK0183","BK0012","BK0187","BK0188","BK1593","BK0239"],"gpt_icon":0},{"id":"2529132158","title":"三生製藥04月22日主力淨流入764萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529132158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529132158?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 16:17","pubTimestamp":1745309832,"startTime":"0","endTime":"0","summary":"04月22日, 三生制药股价涨4.68%，报收12.52元，成交金额5.35亿元，换手率1.79%，振幅7.36%，量比0.96。三生制药今日主力资金净流入764万元，上一交易日主力净流出291万元。该股近5个交易日下跌0.97%，主力资金累计净流入6459万元；近20日主力资金累计净流入3.28亿元，其中净流入天数为16日。该股主力净额占比0.03%，港股市场排名222/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171639a6c38d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171639a6c38d1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2529297723","title":"四環醫藥04月22日主力淨流入924萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529297723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529297723?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 16:16","pubTimestamp":1745309773,"startTime":"0","endTime":"0","summary":"04月22日, 四环医药股价涨4.76%，报收0.66元，成交金额3038万元，换手率0.51%，振幅4.76%，量比1.95。四环医药今日主力资金净流入924万元，上一交易日主力净流出92万元。该股近5个交易日上涨1.59%，主力资金累计净流入960万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2066万元，其中净流入天数为11日。该股主力净额占比0.16%，港股市场排名48/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171112a6c38b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171112a6c38b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":116,"code":"91000000","status":"200"}]}}